Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MICHELLE A.T. HILDEBRANDT and KAREN H LU.
MICHELLE A.T. HILDEBRANDT
Connection Strength
1.084
KAREN H LU
  1. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 May; 30(5):630-631.
    View in: PubMed
    Score: 0.054
  2. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 03; 30(3):349-362.
    View in: PubMed
    Score: 0.053
  3. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers. Cancer Epidemiol Biomarkers Prev. 2021 01; 30(1):217-228.
    View in: PubMed
    Score: 0.049
  4. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. Int J Mol Sci. 2018 08 21; 19(9).
    View in: PubMed
    Score: 0.042
  5. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One. 2018; 13(7):e0197561.
    View in: PubMed
    Score: 0.041
  6. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 04; 118(8):1123-1129.
    View in: PubMed
    Score: 0.040
  7. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017 May; 49(5):680-691.
    View in: PubMed
    Score: 0.038
  8. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer. 2017 Feb 14; 116(4):524-535.
    View in: PubMed
    Score: 0.037
  9. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 2016 11 08; 7(45):72381-72394.
    View in: PubMed
    Score: 0.037
  10. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016 10 25; 7(43):69097-69110.
    View in: PubMed
    Score: 0.037
  11. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. 2016 12; 53(12):800-811.
    View in: PubMed
    Score: 0.036
  12. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol. 2016 10; 45(5):1619-1630.
    View in: PubMed
    Score: 0.036
  13. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov. 2016 09; 6(9):1052-67.
    View in: PubMed
    Score: 0.036
  14. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol. 2016 06; 45(3):884-95.
    View in: PubMed
    Score: 0.036
  15. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet. 2016 07; 135(7):741-56.
    View in: PubMed
    Score: 0.035
  16. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis. 2015 Nov; 36(11):1341-53.
    View in: PubMed
    Score: 0.034
  17. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol. 2015 Dec; 39(8):689-97.
    View in: PubMed
    Score: 0.034
  18. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun. 2015 Sep 22; 6:8234.
    View in: PubMed
    Score: 0.034
  19. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res. 2015; 2(2).
    View in: PubMed
    Score: 0.034
  20. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet. 2015 Oct 15; 24(20):5955-64.
    View in: PubMed
    Score: 0.034
  21. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1574-84.
    View in: PubMed
    Score: 0.034
  22. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One. 2015; 10(6):e0128106.
    View in: PubMed
    Score: 0.033
  23. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb; 47(2):164-71.
    View in: PubMed
    Score: 0.032
  24. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol. 2015 Mar; 136(3):542-8.
    View in: PubMed
    Score: 0.032
  25. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res. 2014 Oct; 58(10):2023-35.
    View in: PubMed
    Score: 0.031
  26. Risk of ovarian cancer and the NF-?B pathway: genetic association with IL1A and TNFSF10. Cancer Res. 2014 Feb 01; 74(3):852-61.
    View in: PubMed
    Score: 0.030
  27. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014 May; 133(5):481-97.
    View in: PubMed
    Score: 0.030
  28. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin Chem. 2014 Jan; 60(1):222-32.
    View in: PubMed
    Score: 0.030
  29. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun. 2013; 4:1628.
    View in: PubMed
    Score: 0.028
  30. Genetic variants in TGF-? pathway are associated with ovarian cancer risk. PLoS One. 2011; 6(9):e25559.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.